C. R. Calabria is a New Orleans–based freelance writer and longtime Phase I clinical trial participant. Read more at corytherat.com or in his newsletter, Pharmascenery. This story was copublished and supported by the journalism nonprofit The Economic Hardship Reporting Project.
